- Active Ingredients
Product Documentation
-
View RMM (Lenalidomide Information for the Patients)
Last updated on this site: 30 Oct 2024
Updated to v2.0
View RMM (Lenalidomide Patient Information Card)Last updated on this site: 30 Oct 2024
Updated
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintLenalidomide Accord 25mg Hard Capsules
- PL Number:
- EU/1/18/1316/001-014
- MA Holder:
- Accord Healthcare S.L.U
- Product Classification:
-
POM
- Product Status:
- Active
Product Documentation
-
View Patient Information Leaflet (PIL - Lenalidomide Accord 2.5mg, 5mg, 7.5mg, 10mg, 15mg, 20mg, 25mg Hard Capsules)
Last updated on this site: 17 Jul 2023
Website administration update only- no change to file.
View Summary of Product Characteristics (SmPC - Lenalidomide Accord 2.5mg, 5mg, 7.5mg, 10mg, 15mg, 20mg, 25mg Hard Capsules)Last updated on this site: 17 Jul 2023
Website administration update only- no change to file.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaint
For any further assistance, please get in touch.